editor.ajphr@gmail.com
9409046853
e-ISSN: 2321-3647
logo

American Journal of Pharmacy and Health Research

📢 Latest Update: Call for Papers for a Peer Reviewed Open Access Pharmacy Journal with Fast Publication

📢 Latest Update: Call for Papers for a Peer Reviewed Open Access Pharmacy Journal with Fast Publication

Volume 13, Issue 2 - 2025 (February 2025 Issue 02)

Volume 13 Issue 2 Cover

Issue Details:

Volume 13 Issue 2
Published:Invalid Date

Editorial: February 2025 Issue 02

Welcome to the 2025 issue of American Journal of Pharmacy and Health Research. This issue showcases the remarkable breadth and depth of contemporary research across multiple disciplines. From cutting-edge applications of machine learning in climate science to the revolutionary potential of quantum computing in drug discovery, our featured articles demonstrate the power of interdisciplinary collaboration in addressing global challenges.

We are particularly excited to present research that bridges traditional academic boundaries, reflecting our journal's commitment to fostering innovation through cross-disciplinary dialogue. The integration of artificial intelligence with environmental science, the application of blockchain technology to supply chain management, and the convergence of urban planning with smart city technologies exemplify the transformative potential of collaborative research.

As we continue to navigate an era of rapid technological advancement and global challenges, the research presented in this issue offers both insights and solutions that will shape our future. We thank our authors, reviewers, and editorial board members for their continued dedication to advancing knowledge and promoting scientific excellence.

Dr H J Patel
Editor-in-Chief
American Journal of Pharmacy and Health Research

Articles in This Issue

Showing 1 of 1 articles
Research PaperID: AJPHR1302001

Evaluation of In-vitro Anticancer Screening Using SRB Assay on Human Cell Lines of Various Extracts of Globally Endangered Ethnomedicinal Tree Species Adansonia digitata L.

Shama Nazrin, Rajinikanth Marka and Rama Swamy Nanna

ABSTRACTThe species Adansonia digitata L is commonly called as baobab belongs to family Bombacaceae. In the present report, we have evaluated the in vitro anticancer activity based on its reported phytoconstituents. The extracts of callus, stem, root, leaf and fruit pulp were obtained using solvents like methanol, hexane and ethyl acetate by Soxhlet extraction method (organic). The in-vitro anticancer activity was evaluated against four human cancer cell lines Colo-205 (Colon cancer cell line), DU-125 (Prostate cancer cell line), MCF-7 (Breast cancer cell line) and HeLa (Cervix cancer cell line) using Sulforhodamine B (SRB) assay. The cytotoxic potential of DU-125 cell lines was examined, and the results showed that the GI50 value of the methanolic callus, methanolic leaf, hexane leaf, and ethyl acetate leaf extracts was >80 µg/ml. The GI50 values of the leaf extracts in hexane and ethyl acetate were found to be >80 µg/ml on the Colo-205 cell line. For the MCF-7 cell line, methanolic callus extracts GI50 values were noted >80 µg/ml and hexane and ethyl acetate leaf extracts were recorded <80 µg/ml (54.6 µg/ml and 52.6 µg/ml).  Methanolic root and leaf extracts were found to have GI50 values  >80 µg/ml on the HeLa cell lines, while hexane and ethyl acetate leaf extracts had GI50 values of 71.2 µg/ml and 76.2 µg/ml, respectively. These findings introduce A. digitata as potentially useful as anti-cancer agent. Keywords: Adansonia digitata, Sulforhodamine B, callus, stem, root, leaf, fruit pulp extracts, human cell lines

Adansonia digitataSulforhodamine Bcallusstemrootleaf+2 more
110,048 views
32,983 downloads

Contributors:

 Shama Nazrin
,
 Rajinikanth Marka and Rama Swamy Nanna
Whatsapp